Stage IIA Cervical Cancer AJCC v8
generalStage IIA2 includes: T2a2, Any N, M0. T2a2: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. Clinically visible lesion more than 4.0 cm in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)
12
Centers
1
Active Trials
—
Cancer Funding
Top Centers for Stage IIA Cervical Cancer AJCC v8(12)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 74.8 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 52.3 |
| 3 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 52.3 |
| 4 | NCI Comprehensive | 52.3 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 52.3 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 52.3 |
| 7 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 52.3 |
| 8 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 52.3 |
| 9 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 52.3 |
| 10 | Cleveland Clinic Cancer CenterCleveland, OH | 52.3 |
| 11 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | 52.3 |
| 12 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 52.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →